Meriwether Wealth & Planning’s Viking Therapeutics VKTX Stock Holding History

Meriwether Wealth & Planning’s Portfolio VKTX Stock Details VKTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$34.9K	Buy	+1,072	New	+$37.1K	0.02%	295

Other funds holding VKTX

Concurrent Investment Advisors Tampa, Florida $14.5B AUM 24.52% 1-Year Est. Return

TGY2IT

Timothy G. Youngquist 2020 Irrevocable Trust Fort Myers, Florida $530M AUM 95.29% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return

Oppenheimer & Co New York $9.5B AUM 27.65% 1-Year Est. Return

Quantum Private Wealth Tampa, Florida $391M AUM 50.76% 1-Year Est. Return

Exchange Traded Concepts Oklahoma City, Oklahoma $25.3B AUM 51.52% 1-Year Est. Return

Lewis Asset Management Lafayette, California $294M AUM 25.62% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return

MN Wealth Advisors Overland Park, Kansas $247M AUM 16.11% 1-Year Est. Return

Meriwether Wealth & Planning's VKTX Position: Q3 2026 in Review

Meriwether Wealth & Planning opened a new position in Viking Therapeutics (VKTX) in Q3 2026: 1,072 shares worth $34.9K. The stake represents 0.02% of the portfolio and ranks #295 among its holdings.

106 funds tracked by Wall St. Rank hold VKTX as of Q3 2026.

Meriwether Wealth & Planning held 1,072 shares of Viking Therapeutics worth $34.9K as of Q3 2026.
Viking Therapeutics was a new Meriwether Wealth & Planning position in Q3 2026.
Viking Therapeutics made up 0.02% of Meriwether Wealth & Planning's portfolio in Q3 2026, its #295 holding.
106 funds tracked by Wall St. Rank held Viking Therapeutics as of Q3 2026.

Based on Meriwether Wealth & Planning's 13F filing for Q3 2026, filed 13 Oct 2026.